PrimeRFP SCOUT · Federal Contract Recompete Brief

W81XWH20C0116Jw190426 fy19 NEW START — Seattle Institute for Biomedical and Clinical Research

Seattle Institute for Biomedical and Clinical Research holds — across 1 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 24, 2026 PoP end — agencies typically plan 12–18 months ahead.

W4pz Usa Med Rsch Acquis Act
Awarding office
Seattle Institute for Biomedical and Clinical Research
Recipient
Sep 24, 2026
PoP end
$0
Obligated
$4.5M
Potential
541715
NAICS
AN93
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Seattle Institute for Biomedical and Clinical Research — $90

Contract facts

NONE
Contract numberW81XWH20C0116
Also listed asW81XWH-20-C-0116
AgencyW4pz Usa Med Rsch Acquis Act
Awarding officeW4pz Usa Med Rsch Acquis Act
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentSeattle Institute for Biomedical and Clinical Research
CAGE3RNX5
UEIDRRKVZVXSND3
NAICS541715
PSCAN93
Place of performanceSEATTLE WA
Pricing typeFixed Price Level Of Effort
Extent competedNot Competed
Related solicitationW81XWH19RJWMR
PoP startSep 25, 2020
PoP end (current)Sep 24, 2026
Obligated$0
Current value$4.5M
Potential value$4.5M

JW190426 FY19 NEW START is a federal NONE award for W4pz Usa Med Rsch Acquis Act held by Seattle Institute for Biomedical and Clinical Research. Estimated value $4.5M ($0 obligated). Current period of performance ends Sep 24, 2026. Last award drew 1 bidder. Place of performance: SEATTLE WA. Related solicitation W81XWH19RJWMR.

Recompete timing

Public
Expiring in 35 days

Current PoP ends Sep 24, 2026 (35 days remaining). Agencies typically plan 12–18 months ahead — at 1.1 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Seattle Institute for Biomedical and Clinical Research obligated across 1 awards (firm-wide, all agencies).

Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81XWH20C0116?

W81XWH20C0116 (Jw190426 fy19 NEW START) is a W4pz Usa Med Rsch Acquis Act award with a potential value of $4.5M, currently held by Seattle Institute for Biomedical and Clinical Research. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81XWH-20-C-0116?

W81XWH-20-C-0116 is the dashed form of PIID W81XWH20C0116 (Jw190426 fy19 NEW START), held by Seattle Institute for Biomedical and Clinical Research. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81XWH20C0116?

W4pz Usa Med Rsch Acquis Act awarded W81XWH20C0116 to Seattle Institute for Biomedical and Clinical Research (potential $4.5M).

Who is the incumbent on W81XWH20C0116?

Seattle Institute for Biomedical and Clinical Research is the incumbent with — across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2026.

When does Seattle Institute for Biomedical and Clinical Research’s W81XWH20C0116 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 24, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81XWH20C0116